Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Estrella Immunopharma (ESLAW) Q3 2025 Earnings
ESLAW
12
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.12
-0.1
-0.09
-0.07
Details
Expected EPS
-0.07
Actual EPS
-0.0676
Surprise EPS
0
Surprise Percent
+3.43%
Description
Estrella Immunopharma (ESLAW) has reported earnings of -0.0676 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login